瞬时无波形比值与血流储备分数指导经皮冠状动脉介入治疗的比较
该多中心、随机、对照、开放标签临床试验通过瑞典冠状动脉造影和血管成形术登记处纳入2037例有生理学指导评估指征的稳定型心绞痛或急性冠脉综合征患者,随机分为iFR指导血运重建组或FFR指导血运重建组。主要终点为术后12个月内全因死亡、非致死性心肌梗死或非计划血运重建的复合终点。iFR组1012例中68例(6.7%)发生主要终点事件,FFR组1007例中61例(6.1%)发生,事件率差0.7个百分点(95%CI -1.5至2.8),非劣效性P=0.007,风险比1.12(95%CI 0.79至1.58;P=0.53),事件率差95%CI上限落在预设非劣效界值3.2个百分点内。心肌梗死、靶病变血运重建、再狭窄和支架血栓发生率两组间无显著差异;FFR组术中报告胸部不适的患者比例显著高于iFR组。
要点
- iFR指导组12个月主要终点事件率6.7%(68/1012) vs FFR指导组6.1%(61/1007),事件率差0.7个百分点(95%CI -1.5至2.8),非劣效性P=0.007。
- 风险比1.12(95%CI 0.79至1.58;P=0.53),事件率差95%CI上限2.8个百分点,落在预设非劣效界值3.2个百分点内。
- 心肌梗死、靶病变血运重建、再狭窄和支架血栓发生率两组间无显著差异。
- FFR组术中报告胸部不适的患者比例显著高于iFR组。
- 主要亚组间结果相似。
适用人群与场景
- 稳定型心绞痛或急性冠脉综合征、有生理学指导评估冠状动脉狭窄指征的患者,共2037例,通过瑞典冠状动脉造影和血管成形术登记处纳入。
研究设计与关键结果
- 研究类型:多中心、随机、对照、开放标签临床试验,通过瑞典冠状动脉造影和血管成形术登记处入组,共2037例。
- 干预与对照:随机分配接受iFR指导的血运重建(1012例)或FFR指导的血运重建(1007例)。
- 主要终点:术后12个月内全因死亡、非致死性心肌梗死或非计划血运重建的复合终点;iFR组68/1012(6.7%) vs FFR组61/1007(6.1%),事件率差0.7个百分点(95%CI -1.5至2.8),非劣效性P=0.007,风险比1.12(95%CI 0.79至1.58;P=0.53)。
- 非劣效性:事件率差95%CI上限落在预设非劣效界值3.2个百分点内。
- 关键次要终点:心肌梗死、靶病变血运重建、再狭窄和支架血栓发生率两组间无显著差异。
- 不良事件:FFR组术中报告胸部不适的患者比例显著高于iFR组。
- 亚组:主要亚组间结果相似。
证据类型、等级与局限
- 证据类型:多中心随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在稳定型心绞痛或急性冠脉综合征、有生理学指导评估冠脉狭窄指征的患者中,iFR指导的血运重建策略在12个月主要不良心血管事件方面不劣于FFR指导策略,支持iFR作为FFR的替代生理学评估指标用于指导血运重建。
- FFR组术中胸部不适的患者比例显著高于iFR组。
指南或共识出处
- iFR SWEDEHEART,ClinicalTrials.gov注册号NCT02166736,由Philips Volcano资助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The instantaneous wave-free ratio (iFR) is an index used to assess the severity of coronary-artery stenosis. The index has been tested against fractional flow reserve (FFR) in small trials, and the two measures have been found to have similar diagnostic accuracy. However, studies of clinical outcomes associated with the use of iFR are lacking. We aimed to evaluate whether iFR is noninferior to FFR with respect to the rate of subsequent major adverse cardiac events.
METHODS: We conducted a multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enrollment. A total of 2037 participants with stable angina or an acute coronary syndrome who had an indication for physiologically guided assessment of coronary-artery stenosis were randomly assigned to undergo revascularization guided by either iFR or FFR. The primary end point was the rate of a composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization within 12 months after the procedure.
RESULTS: A primary end-point event occurred in 68 of 1012 patients (6.7%) in the iFR group and in 61 of 1007 (6.1%) in the FFR group (difference in event rates, 0.7 percentage points; 95% confidence interval [CI], -1.5 to 2.8; P=0.007 for noninferiority; hazard ratio, 1.12; 95% CI, 0.79 to 1.58; P=0.53); the upper limit of the 95% confidence interval for the difference in event rates fell within the prespecified noninferiority margin of 3.2 percentage points. The results were similar among major subgroups. The rates of myocardial infarction, target-lesion revascularization, restenosis, and stent thrombosis did not differ significantly between the two groups. A significantly higher proportion of patients in the FFR group than in the iFR group reported chest discomfort during the procedure.
CONCLUSIONS: Among patients with stable angina or an acute coronary syndrome, an iFR-guided revascularization strategy was noninferior to an FFR-guided revascularization strategy with respect to the rate of major adverse cardiac events at 12 months. (Funded by Philips Volcano; iFR SWEDEHEART ClinicalTrials.gov number, NCT02166736 .).
参考来源
- Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017. PMID: 28317438. doi:10.1056/NEJMoa1616540
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。